The Asian Fund for Cancer Research (AFCR) is proud to present the BRACE Award, Bridging Research from Academia to Cancer Entrepreneurship. The BRACE Award aims to provide vital support to early-stage biotechs, enabling them to accelerate their innovative therapeutics, diagnostics and cancer prevention products into the clinic, with the ultimate goal of improving outcomes for patients affected by cancer globally.
The winning company will receive up to US$600,000 in investment funding from AFCR and co-investors, subject to due diligence and negotiation, which will serve as early seed money for proof of concept and proof of value on the path to clinical trials and, eventually, to new effective cancer technologies that could save patients’ lives.
2022 BRACE Award Venture Competition
The Asian Fund for Cancer Research congratulates our five semi-finalists of the 2022 BRACE Award Venture Competition. The BRACE Award aims to accelerate the development of innovative discoveries into better, more effective treatments and technologies for cancers prevalent in Asian populations. These five startups’ innovative technologies will bring new hope to cancer patients.
Sign up for e-mails to learn about future BRACE Award Competitions and other developments.